|
KMID : 0869620190360030335
|
|
Journal of Korean Society of Hospital Pharmacists
2019 Volume.36 No. 3 p.335 ~ p.343
|
|
|
Prevention of Hepatic Veno-Occlusive Disease with Pentoxifylline after Allogeneic Hematopoietic Stem Cell Transplantation
|
|
Kim Nam-Hee
Lee So-Young
Kim Jae-Song
Son Eun-Sun
|
|
|
Abstract
|
|
|
Background : Veno-occlusive disease (VOD) is a potentially devastating complication that can develop after hematopoietic stem cell transplantation (HSCT). The incidence is higher for allogeneic than autologous HSCT. Previous studies on the prevention of VOD with pentoxifylline have limitations to apply for the present state due to the difference of VOD criteria.
This study examines the effectiveness of pentoxifylline in preventing VOD according to current diagnostic criteria for a patient with allogeneic HSCT.
Methods : Allogeneic HSCT recipients from 2013 to 2018 were selected for this retrospective analysis. Subjects were divided into three groups depending on pentoxifylline administration.
The first and the second group took pentoxifylline for more than two weeks and for less than two weeks respectively, while the last group did not take it. The primary endpoints were the incidence rates of VOD. Secondary endpoints were hyperbilirubinemia (≥2 mg/dL), weight gain (>5% of baseline), painful hepatomegaly, ascites, and taking VOD treatment (defibrotide) or liver function agent.
Results : 210 patients were included. The incidence rate of VOD was 5.0% in the first group vs. 6.5% in the second group vs. 6.5% in the last group (p=0.779). There was no significantly difference in hyperbilirubinemia (p=0.844), weight gain (p=0.292), painful hepatomegaly (p=0.093), ascites (p=0.912), taking defibrotide (p=0.886), taking liver function agent (p=0.508).
Conclusions : This study confirmed that there is no VOD prevention effect of pentoxifylline in patients with allogeneic HSCT. Further studies are needed to develop more effectiveness prophylactic approaches of VOD.
|
|
|
KEYWORD
|
|
|
Pentoxifylline, Prophylaxis, VOD (Veno-Occlusive Disease), Allogeneic hematopoietic stem cell transplantation
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|